Croxen R, Hattan C, Shellay C, et al: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology 59:162, 2002.
Dalakas MC, Engel WK: Treatment of “permanent” muscle weakness in familial hypokalemic periodic paralysis. Muscle Nerve 6:182, 1983.
Dalakas MC, Fugii M, Li M, et al: High dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 345:1870, 2001.
Dalakas MC, Rakocevic G, Dambrosia JM, et al: A double-blind, placebo controlled study of rituxumab in patients with stiff person syndrome. Ann Neurol 82:271, 2017.
Dau PC, Denys EH: Plasmapheresis and immunosuppressive therapy in the Eaton-Lambert syndrome. Ann Neurol 11:570, 1982.
De Feo LG, Schottlender J, Martelli NA, et al: Use of intravenous pulsed cyclophosphamide in severe generalized myasthenia gravis. Muscle Nerve 26:31, 2002.
DeJong JGY: Myotonia levior, in Kuhn E (ed): Progressive
Muskeldystrophie-Myotonie-Myasthenie. Heidelberg, Springer, 1966, pp 255–259.
Denborough MA: Malignant hyperthermia. Lancet 352:1131, 1998.
Denborough MA, Forster JF, Lovell RR: Anaesthetic deaths in a family. Br J Anaesth 1962:34, 395.
Denny-Brown D, Nevin S: The phenomenon of myotonia. Brain 64:1, 1941.
Diaz-Manera J, Matinez-Hernandez E, Querol L, et al: Long- lasting effect of rituximab in MuSK myasthenia. Neurology 78:189, 2012.
Drachman DB: How to recognize an antibody-mediated autoimmune disease: Criteria. Res Publ Assoc Res Nerv Ment Dis 68:183, 1990.
Drachman DB: Myasthenia gravis. N Engl J Med 298:136, 186, 1978.
Drachman DB: Myasthenia gravis. N Engl J Med 330:1797, 1994.
Drachman DB, Jones RJ, Brodsky RA: Treatment of refractory myasthenia: “Rebooting” with high dose cyclophosphamide. Ann Neurol 53:29, 2003.
Eaton LM, Lambert EH: Electromyography and electric stimulation of nerves and diseases of motor unit: Observations on myasthenic syndrome associated with malignant tumors. JAMA 163:1117, 1957.
Elmquist D, Lambert EH: Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome, sometimes associated with bronchial carcinoma. Mayo Clin Proc 43:689, 1968.
Engel AG: Evolution and content of vacuoles in primary hypokalemic periodic paralysis. Mayo Clin Proc 45:774, 1970.
Engel AG: Congenital myasthenic syndromes, in Engel AG (ed): Myasthenia Gravis and Myasthenic Disorders. New York, Oxford University Press, 1999, pp 251–297.
Engel AG (ed): Myasthenia Gravis and Myasthenic Disorders. New York, Oxford University Press, 1999.